Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli?

被引:20
作者
Bergman, M
Salman, H
Beloosesky, Y
Djaldetti, M
Bessler, T
机构
[1] Rabin Med Ctr, Lab Immunol & Hematol Res, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Dept Med C, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Geriatr, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel
关键词
Alzheimer disease; apoptosis; cytokines;
D O I
10.1097/00002093-200207000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
One of the reasons for the increased susceptibility to infections in patients with Alzheimer disease may be enhanced apoptotic death of their peripheral leukocytes. If this is the case, the enhanced apoptosis may be due to components in the patients' sera or to an increased sensitivity of the cells to apoptotic Stimuli. To examine this possibility, the percentage of apoptotic cells in the peripheral blood mononuclear cells (PBMC) from 12 patients with Alzheimer disease was compared with that of 12 age-matched non-demented persons and 12 middle-aged healthy control subjects. In addition, the effect of sera from subjects in the three groups on the apoptosis, interleukin (IL)-1beta, IL-2, IL-6, IL-10, and tumor necrosis factor (TNF)alpha production by peripheral b1cod cells from healthy control subjects was examined. It was found that the percentage of apoptotic PBMC from patients with Alzheimer disease was higher than that from the remaining two groups. However, incubation of control cells with sera from patients with Alzheimer disease and non-demented elderly persons did not affect the number of apoptotic cells. Sera from patients with Alzheimer disease and non-demented elderly subjects caused an increase in IL-2 and a decrease in IL-10 production by PBMC from middle-aged control subjects but did not affect IL-1beta, IL-6, and TNFalpha secretion, indicating alterations of the immune system related to aging.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 19 条
[1]
*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133
[2]
Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections [J].
Bruunsgaard, H ;
Skinhoj, P ;
Qvist, J ;
Pedersen, BK .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :551-554
[3]
Dragunow M, 1997, REV NEUROSCIENCE, V8, P223
[4]
Eckert A, 1998, J NEURAL TRANSM-SUPP, P259
[5]
Eilat E, 1999, J IMMUNOL, V163, P533
[6]
Changes in apoptosis of human polymorphonuclear granulocytes with aging [J].
Fulop, T ;
Fouquet, C ;
Allaire, P ;
Perrin, N ;
Lacombe, G ;
Stankova, J ;
RolaPleszczynski, M ;
Gagne, D ;
Wagner, JR ;
Khalil, A ;
Dupuis, G .
MECHANISMS OF AGEING AND DEVELOPMENT, 1997, 96 (1-3) :15-34
[7]
Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans [J].
Gupta, S .
VACCINE, 2000, 18 (16) :1596-1601
[8]
Kira J, 1997, ACTA NEUROL SCAND, V96, P305, DOI 10.1111/j.1600-0404.1997.tb00288.x
[9]
Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals [J].
Lombardi, VRM ;
García, M ;
Rey, L ;
Cacabelos, R .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) :163-171
[10]
MAESAKA JK, 1999, AM J PHYSIOL, V6, pF521